Veterinary Referral Center of Central Oregon Strengthens Specialty Care With Board-Certified Anesthesiologist
VRCCO Welcomes New Specialists and Expanded Service Offerings BEND, OREGON / ACCESS Newswire / August 26, 2025 / The Veterinary...
VRCCO Welcomes New Specialists and Expanded Service Offerings BEND, OREGON / ACCESS Newswire / August 26, 2025 / The Veterinary...
Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum...
HUNTSVILLE, AL / ACCESS Newswire / August 26, 2025 / Curiteva, Inc., a leading technology and manufacturing company, proudly announces...
Five Iconic Michael Jordan Game-Worn Sneakers Headline Elite Sports Memorabilia Auction MESA, ARIZONA / ACCESS Newswire / August 26, 2025...
BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and...
From diagnosis to doorstep: DrHouse launches the first end-to-end telehealth app in Florida, from doctor visit to complimentary 1-hour prescription...
MECHANICSBURG, PENNSYLVANIA / ACCESS Newswire / August 26, 2025 / PA Health & Wellness, a company of Centene Corporation, has...
Building on more than 20 years of data and expertise, AMC Health announces a major expansion of its virtual care...
LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global,...
-More than 6,000 MODD1 cartridges produced- Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA...
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS...
Pharmacy Leader and FAMU Alumnus Stan Loomis Received Top Honor, Inspire Future Pharmacists as Keynote SpeakerORLANDO, Fla., Aug. 26, 2025...
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX...
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary...
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused...
A new partnership brings together a validated discovery platform and cutting-edge computational innovation in targeted protein degradationVIENNA and LAUSANNE, Switzerland,...
TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase...
Company advancing U.S. commercialization with FDA-approved ketamine and rare disorder NDA filingsTORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings...
TEL AVIV, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a...
Targeting the Multi-Trillion Dollar Longevity Market Jupiter, Florida, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter”...